刊名:Neuromodulation: Technology at the Neural Interface
出版年:2017
出版时间:February 2017
年:2017
卷:20
期:2
页码:133-154
全文大小:435K
ISSN:1525-1403
文摘
Intrathecal (IT) drug infusion is an appropriate and necessary tool in the algorithm to treat refractory cancer and noncancer pain. The decision-making steps/methodology for selecting appropriate patients for implanted targeted drug delivery systems is controversial and complicated. Therefore, a consensus on best practices for determining appropriate use of IT drug infusion may involve testing/trialing this therapy before implantation.